Published in Cancer Weekly, December 8th, 2009
"The appointment of Akbar Seddigh brings additional strength in business development to the board," said LSO's Chairman of the Board Jeff Himawan. "Mr. Seddigh is a world leader in cancer-therapy business development. He has overseen the emergence of Elekta as the market leader in radiation treatment in oncology -- a much larger market than drug treatment in oncology."
"Akbar...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-12-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.